LENSAR, Inc. (NasdaqCM: LNSR)
Health Care · Health Care Equipment & Supplies · US
$6.45
-4.44% today · -44.6% 1Y
LENSAR, Inc. (NasdaqCM: LNSR) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $82.93M and employs 150 people.
Over the last twelve months the share price has lost 44.6%, trading between 4.95 and 12.94.
Tweenvest scores LENSAR, Inc. across four factors: quality 60/100, value 57/100, growth 85/100. Its strongest factor is growth.
LNSR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $82.93M
- Revenue (TTM)
- $60.26M
- P/E
- 12.72
- EPS
- 0.53
- Dividend yield
- —
- Beta (5Y)
- 0.95
- 52-week high
- $12.94
- 52-week low
- $4.95
- Avg volume (3M)
- —
- Shares outstanding
- 12.29M
- Employees
- 150
- Next earnings
- —
About LENSAR, Inc.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
- ISIN
- US52634L1089
- Founded
- 2004
- Listed since
- Oct 2, 2020
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Colan Totte.Co.,Ltd.TSE: 7792 | $85.77M | ¥1,487.00 | +0.20% |
| Nexstim PlcHLSE: NXTMH | $85.43M | €9.01 | -4.15% |
| HCmed Innovations Co., Ltd.TWSE: 6934 | $83.82M | NT$73.90 | -2.12% |
| Solborn, Inc.KOSDAQ: A035610 | $83.01M | ₩4,895.00 | -3.26% |
| T&R Biofab Co., Ltd.KOSDAQ: A246710 | $82.10M | ₩2,320.00 | +1.31% |
| OPTUS Pharmaceutical Co., Ltd.KOSDAQ: A131030 | $81.76M | ₩6,240.00 | +6.85% |
| Gaush Meditech LtdSEHK: 2407 | $81.10M | HK$4.50 | -2.07% |
| Taiko Pharmaceutical Co.,Ltd.TSE: 4574 | $80.38M | ¥252.00 | -2.70% |
Figures last refreshed Oct 4, 2026.